Literature DB >> 20824363

Pre-operative nomogram to predict risk of peri-operative mortality following liver resections for malignancy.

Mashaal Dhir1, Lynette M Smith, Fred Ullrich, Premila D Leiphrakpam, Quan P Ly, Aaron R Sasson, Chandrakanth Are.   

Abstract

INTRODUCTION: The majority of liver resections for malignancy are performed in older patient with major co-morbidities. There is currently no pre-operative, patient-specific method to determine the likely peri-operative mortality for each individual patient. The aim of this study was to develop a pre-operative nomogram based on the presence of co-morbidities to predict risk of peri-operative mortality following liver resections for malignancy.
METHODS: The Nationwide Inpatient Sample database was queried to identify adult patients that underwent liver resection for malignancy. The pre-operative co-morbidities, identified as predictors were used and a nomogram was created with multivariate regression using Taylor expansion method in SAS software, surveylogistic procedure. Training set (years 2000-2004) was utilized to develop the model and validation set (year 2005) was utilized to validate this model.
RESULTS: A total of 3,947 and 972 patients were included in training and validation sets, respectively. The overall actual-observed peri-operative mortality rates for training and validation sets were 4.1% and 3.2%, respectively. The decile-based calibration plots for the training set revealed good agreement between the observed probabilities and nomogram-predicted probabilities. Similarly, the quartile-based calibration plot for the validation set revealed good agreement between the observed and predicted probabilities. The accuracy of the nomogram was further reinforced by a good concordance index of 0.80 with a 95% confidence interval of 0.72 and 0.87.
CONCLUSIONS: This pre-operative nomogram may be utilized to predict the risk of peri-operative mortality following liver resection for malignancy.

Entities:  

Mesh:

Year:  2010        PMID: 20824363     DOI: 10.1007/s11605-010-1352-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

Review 1.  Preoperative portal vein embolization: indications and technical considerations.

Authors:  Thierry de Baere; Alban Denys; David C Madoff
Journal:  Tech Vasc Interv Radiol       Date:  2007-03

Review 2.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

3.  Perioperative risk assessment for hepatocellular carcinoma by using the MELD score.

Authors:  Spiros G Delis; Andreas Bakoyiannis; Christos Dervenis; Nikos Tassopoulos
Journal:  J Gastrointest Surg       Date:  2009-08-07       Impact factor: 3.452

4.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Authors:  G Torzilli; M Makuuchi; K Inoue; T Takayama; Y Sakamoto; Y Sugawara; K Kubota; A Zucchi
Journal:  Arch Surg       Date:  1999-09

5.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Predictive indices of morbidity and mortality after liver resection.

Authors:  Rebecca A Schroeder; Carlos E Marroquin; Barbara Phillips Bute; Shukri Khuri; William G Henderson; Paul C Kuo
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

7.  Perioperative mortality for management of hepatic neoplasm: a simple risk score.

Authors:  Jessica P Simons; Joshua S Hill; Sing Chau Ng; Shimul A Shah; Zheng Zhou; Giles F Whalen; Jennifer F Tseng
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

Review 8.  Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.

Authors:  R Adam
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

Review 9.  Expanding criteria for resectability of colorectal liver metastases.

Authors:  Timothy M Pawlik; Richard D Schulick; Michael A Choti
Journal:  Oncologist       Date:  2008-01

Review 10.  Operative mortality after hepatic resection: are literature-based rates broadly applicable?

Authors:  Bolanle Asiyanbola; David Chang; Ana Luiza Gleisner; Hari Nathan; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-02-12       Impact factor: 3.452

View more
  5 in total

1.  External validation of a pre-operative nomogram predicting peri-operative mortality risk after liver resections for malignancy.

Authors:  Mashaal Dhir; Srinevas K Reddy; Lynette M Smith; Fred Ullrich; James Wallis Marsh; Allan Tsung; David A Geller; Chandrakanth Are
Journal:  HPB (Oxford)       Date:  2011-09-16       Impact factor: 3.647

2.  A preoperative nomogram to predict the risk of perioperative mortality following gastric resections for malignancy.

Authors:  Mashaal Dhir; Lynette M Smith; Fred Ullrich; Premila D Leiphrakpam; Quan P Ly; Aaron R Sasson; Chandrakanth Are
Journal:  J Gastrointest Surg       Date:  2012-09-05       Impact factor: 3.452

3.  Safety of hepatectomy for elderly patients with hepatocellular carcinoma.

Authors:  Koichi Oishi; Toshiyuki Itamoto; Toshihiko Kohashi; Yasuhiro Matsugu; Hideki Nakahara; Mikiya Kitamoto
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Preoperative Risk Factors for 30-Day Reoperation in Patients Undergoing Hepatic Resections for Malignancy.

Authors:  Jeffrey Douaiher; Tanvir Hussain; Mashaal Dhir; Lynette Smith; Chandrakanth Are
Journal:  Indian J Surg Oncol       Date:  2016-09-08

5.  Early post-operative prediction of morbidity and mortality after a major liver resection for colorectal metastases.

Authors:  Michał Grąt; Wacław Hołówko; Zbigniew Lewandowski; Oskar Kornasiewicz; Krzysztof Barski; Michał Skalski; Krzysztof Zieniewicz; Marek Krawczyk
Journal:  HPB (Oxford)       Date:  2012-10-26       Impact factor: 3.647

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.